middle.news
Tissue Repair Builds Momentum Towards April FDA Submission
12:27pm on Thursday 29th of October, 2026 AEDT
•
Biotechnology
Read Story
Tissue Repair Builds Momentum Towards April FDA Submission
12:27pm on Thursday 29th of October, 2026 AEDT
Key Points
Approximately 112 patients randomised in the US Phase III chronic wound trial
FDA 510(k) submission targeted for April 2027
Potential reimbursement of about US$1,270 per 10g tube in US wound clinics
TR Pro+ 10g, 30g and 200g formats now available in Australia
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Tissue Repair (ASX:TRP)
OPEN ARTICLE